Atlas Trials

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

Clinical trial NCT02820324 · COMPLETED

Trial details

NCT number
NCT02820324
Sponsor
Trevena Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Pain
Start date
2016-05-01
Primary completion
2016-12-01
Enrollment
407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.